Biologics CDMO Secondary Packaging Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025

Description

The global biologics CDMO (Contract Development and Manufacturing Organization) secondary packaging market was valued at USD 1,711.7 million in 2024 and is projected to reach USD 3,299.3 million by 2032, growing at a compound annual growth rate (CAGR) of 8.7% during the forecast period. This growth is driven by the increasing production of biologic drugs, expanding pharmaceutical industries, and the rising prevalence of diseases such as chronic, infectious, and genetic disorders. As the biologics market continues to expand, secondary packaging solutions that ensure the safe transportation and storage of these sensitive products have become increasingly important.

The demand for biologics CDMO secondary packaging is also bolstered by significant investments from key pharmaceutical companies. For instance, Johnson & Johnson committed over $2 billion in October 2024 to establish a state-of-the-art biologics manufacturing facility in North Carolina, and AbbVie made a $223 million investment to expand its Singapore manufacturing site in January 2024. These investments reflect the growing need for biologics packaging solutions that guarantee product integrity and safety.

Key Insights

Mergers & Acquisitions and Partnerships: The biologics CDMO secondary packaging market is witnessing a growing trend of mergers, acquisitions, and partnerships, which are driving industry consolidation and expanding market capabilities. For example, in September 2023, Chime Biologics collaborated with Kings Pharm to accelerate biosimilar launches. Additionally, GHO Capital Partners and Ampersand Capital Partners acquired Avid Bioservices in a $1.1 billion deal in November 2024. Such moves are enabling companies to enhance their manufacturing and packaging capabilities for biologics.

Shift Toward CDMOs: Increasingly, biopharmaceutical companies are turning to CDMOs to manage the cost-intensive processes of drug development and manufacturing. By outsourcing secondary packaging and other production services, companies can reduce capital investment and focus on R&D, which boosts the demand for flexible and cost-effective CDMO services.

Price Increases in Packaging: A significant challenge to market growth is the rising cost of packaging materials, driven by global supply chain disruptions and the increasing demand for packaging in other industries such as e-commerce. Additionally, the Plastics Packaging Tax, which was imposed on plastic packaging that contains less than 30% recycled material, has contributed to the surge in packaging costs.

Boxes dominate the biologics CDMO secondary packaging market, holding a 65% share in 2024. This is due to their suitability for transporting biologic products, including those requiring frozen and controlled ambient conditions. Boxes are custom-engineered to ensure product safety and maintain quality during transit, making them an essential packaging solution for biologics.

Blister Packs are the fastest-growing category in primary packaging, with a 20% share in 2024. Their versatility, transparency, and ability to preserve the integrity of biologics, especially in monodose applications, are driving their increasing demand in the biologics sector.

North America is the largest regional market for biologics CDMO secondary packaging, accounting for 40% of the global market share in 2024. The region is benefiting from high levels of drug R&D outsourcing and the growing demand for innovative and customized packaging solutions for biologics.

Asia-Pacific (APAC) is expected to exhibit the highest growth rate during the forecast period, driven by the increasing prevalence of chronic diseases, the rising focus on contract manufacturing, and the expansion of biologics manufacturing capabilities in the region.

BFSI Sector: The biologics CDMO secondary packaging market for the BFSI (Banking, Financial Services, and Insurance) sector is expected to continue growing rapidly due to the sector's rising vulnerability to cyberattacks and the need for secure packaging solutions for sensitive materials.

Market Fragmentation: The market is fragmented, with numerous players offering specialized solutions for biologics manufacturers. Key players in the market include Catalent Inc., Lonza Group Ltd., WuXi Biologics, Samsung Biologics, and Fujifilm Diosynth Biotechnologies. These companies are expanding their capabilities through mergers, acquisitions, and the introduction of innovative packaging solutions to meet the growing demands of the biologics industry.

Recent Developments: In January 2025, Samsung Biologics entered into a collaboration with LigaChem Biosciences to provide antibody-drug conjugate (ADC) services. Furthermore, Lonza announced plans to focus exclusively on its CDMO business in November 2024, divesting from its capsules and health ingredients business. Additionally, Fujifilm Diosynth Biotechnologies launched the first phase of its global CDMO ecosystem expansion in November 2024. These moves signify the growing importance of specialized CDMO services in the biologics market.

Product Code: 12481

Chapter 1. Research Scope

1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
- 1.4.1. Market Size Breakdown, by Type
- 1.4.2. Market Size Breakdown, by Primary Package Type
- 1.4.3. Market Size Breakdown, by Region
- 1.4.4. Market Size Breakdown, by Country
1.5. Market Data Reporting Unit
- 1.5.1. Revenue
1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence Database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

5.1. Industry Background
5.2. Market Dynamics
- 5.2.1. Trends
- 5.2.2. Drivers
- 5.2.3. Restraints/Challenges
- 5.2.4. Emerging Economies and Key Opportunities
- 5.2.5. Impact Analysis of Drivers/Restraints
5.3. Impact of COVID-19
5.4. Sociopolitical Impact
5.5. Porter's Five Forces Analysis
- 5.5.1. Bargaining Power of Buyers
- 5.5.2. Bargaining Power of Suppliers
- 5.5.3. Threat of New Entrants
- 5.5.4. Intensity of Rivalry
- 5.5.5. Threat of Substitutes
5.6. Innovation and Technology Trends
5.7. Supply Chain and Value Chain Insights
5.8. Economic and Regulatory Impact
5.9. Market Entry Strategies

Chapter 6. Competitive Landscape

6.1. List of Market Players and their Offerings
6.2. Market Share of Key Players (2024)
- 6.2.1. Global
- 6.2.2. North America
- 6.2.3. Europe
- 6.2.4. Asia-Pacific
- 6.2.5. Latin America
- 6.2.6. Middle East & Africa
6.3. Competitive Benchmarking of Key Players
6.4. Product Benchmarking of Key Players
6.5. Recent Strategic Developments by Key Players
6.6. Company Leadership Matrix

Chapter 7. Global Market

7.1. Overview
7.2. Market Revenue, by Type (2019-2032)
7.3. Market Revenue, by Primary Package Type (2019-2032)
7.4. Market Revenue, by Region (2019-2032)

Chapter 8. North America Market

8.1. Overview
8.2. Market Revenue, by Type (2019-2032)
8.3. Market Revenue, by Primary Package Type (2019-2032)
8.4. Market Revenue, by Country (2019-2032)

Chapter 9. Europe Market

9.1. Overview
9.2. Market Revenue, by Type (2019-2032)
9.3. Market Revenue, by Primary Package Type (2019-2032)
9.4. Market Revenue, by Country (2019-2032)

Chapter 10. Asia-Pacific Market

10.1. Overview
10.2. Market Revenue, by Type (2019-2032)
10.3. Market Revenue, by Primary Package Type (2019-2032)
10.4. Market Revenue, by Country (2019-2032)

Chapter 11. Latin America Market

11.1. Overview
11.2. Market Revenue, by Type (2019-2032)
11.3. Market Revenue, by Primary Package Type (2019-2032)
11.4. Market Revenue, by Country (2019-2032)

Chapter 12. Middle East & Africa Market

12.1. Overview
12.2. Market Revenue, by Type (2019-2032)
12.3. Market Revenue, by Primary Package Type (2019-2032)
12.4. Market Revenue, by Country (2019-2032)

Chapter 13. U.S. Market

13.1. Overview
13.2. Economic Indicators
13.3. Demographics and Population Insights
13.4. Regional Hotspots
13.5. Growth Drivers
13.6. Challenges and Barriers
13.7. Competitive Strategies
13.8. Emerging Players
13.9. Import/Export Policies
13.10. Compliance Requirements
13.11. Emerging Investment Areas
13.12. Major Ongoing Projects
13.13. Market Size and Forecast
- 13.13.1. Market Revenue, by Type (2019-2032)
- 13.13.2. Market Revenue, by Primary Package Type (2019-2032)

Chapter 14. Canada Market

14.1. Overview
14.2. Economic Indicators
14.3. Demographics and Population Insights
14.4. Regional Hotspots
14.5. Growth Drivers
14.6. Challenges and Barriers
14.7. Competitive Strategies
14.8. Emerging Players
14.9. Import/Export Policies
14.10. Compliance Requirements
14.11. Emerging Investment Areas
14.12. Major Ongoing Projects
14.13. Market Size and Forecast
- 14.13.1. Market Revenue, by Type (2019-2032)
- 14.13.2. Market Revenue, by Primary Package Type (2019-2032)

Chapter 15. U.K. Market

15.1. Overview
15.2. Economic Indicators
15.3. Demographics and Population Insights
15.4. Regional Hotspots
15.5. Growth Drivers
15.6. Challenges and Barriers
15.7. Competitive Strategies
15.8. Emerging Players
15.9. Import/Export Policies
15.10. Compliance Requirements
15.11. Emerging Investment Areas
15.12. Major Ongoing Projects
15.13. Market Size and Forecast
- 15.13.1. Market Revenue, by Type (2019-2032)
- 15.13.2. Market Revenue, by Primary Package Type (2019-2032)

Chapter 16. Germany Market

16.1. Overview
16.2. Economic Indicators
16.3. Demographics and Population Insights
16.4. Regional Hotspots
16.5. Growth Drivers
16.6. Challenges and Barriers
16.7. Competitive Strategies
16.8. Emerging Players
16.9. Import/Export Policies
16.10. Compliance Requirements
16.11. Emerging Investment Areas
16.12. Major Ongoing Projects
16.13. Market Size and Forecast
- 16.13.1. Market Revenue, by Type (2019-2032)
- 16.13.2. Market Revenue, by Primary Package Type (2019-2032)

Chapter 17. France Market

17.1. Overview
17.2. Economic Indicators
17.3. Demographics and Population Insights
17.4. Regional Hotspots
17.5. Growth Drivers
17.6. Challenges and Barriers
17.7. Competitive Strategies
17.8. Emerging Players
17.9. Import/Export Policies
17.10. Compliance Requirements
17.11. Emerging Investment Areas
17.12. Major Ongoing Projects
17.13. Market Size and Forecast
- 17.13.1. Market Revenue, by Type (2019-2032)
- 17.13.2. Market Revenue, by Primary Package Type (2019-2032)

Chapter 18. Italy Market

18.1. Overview
18.2. Economic Indicators
18.3. Demographics and Population Insights
18.4. Regional Hotspots
18.5. Growth Drivers
18.6. Challenges and Barriers
18.7. Competitive Strategies
18.8. Emerging Players
18.9. Import/Export Policies
18.10. Compliance Requirements
18.11. Emerging Investment Areas
18.12. Major Ongoing Projects
18.13. Market Size and Forecast
- 18.13.1. Market Revenue, by Type (2019-2032)
- 18.13.2. Market Revenue, by Primary Package Type (2019-2032)

Chapter 19. Spain Market

19.1. Overview
19.2. Economic Indicators
19.3. Demographics and Population Insights
19.4. Regional Hotspots
19.5. Growth Drivers
19.6. Challenges and Barriers
19.7. Competitive Strategies
19.8. Emerging Players
19.9. Import/Export Policies
19.10. Compliance Requirements
19.11. Emerging Investment Areas
19.12. Major Ongoing Projects
19.13. Market Size and Forecast
- 19.13.1. Market Revenue, by Type (2019-2032)
- 19.13.2. Market Revenue, by Primary Package Type (2019-2032)

Chapter 20. China Market

20.1. Overview
20.2. Economic Indicators
20.3. Demographics and Population Insights
20.4. Regional Hotspots
20.5. Growth Drivers
20.6. Challenges and Barriers
20.7. Competitive Strategies
20.8. Emerging Players
20.9. Import/Export Policies
20.10. Compliance Requirements
20.11. Emerging Investment Areas
20.12. Major Ongoing Projects
20.13. Market Size and Forecast
- 20.13.1. Market Revenue, by Type (2019-2032)
- 20.13.2. Market Revenue, by Primary Package Type (2019-2032)

Chapter 21. Japan Market

21.1. Overview
21.2. Economic Indicators
21.3. Demographics and Population Insights
21.4. Regional Hotspots
21.5. Growth Drivers
21.6. Challenges and Barriers
21.7. Competitive Strategies
21.8. Emerging Players
21.9. Import/Export Policies
21.10. Compliance Requirements
21.11. Emerging Investment Areas
21.12. Major Ongoing Projects
21.13. Market Size and Forecast
- 21.13.1. Market Revenue, by Type (2019-2032)
- 21.13.2. Market Revenue, by Primary Package Type (2019-2032)

Chapter 22. Australia Market

22.1. Overview
22.2. Economic Indicators
22.3. Demographics and Population Insights
22.4. Regional Hotspots
22.5. Growth Drivers
22.6. Challenges and Barriers
22.7. Competitive Strategies
22.8. Emerging Players
22.9. Import/Export Policies
22.10. Compliance Requirements
22.11. Emerging Investment Areas
22.12. Major Ongoing Projects
22.13. Market Size and Forecast
- 22.13.1. Market Revenue, by Type (2019-2032)
- 22.13.2. Market Revenue, by Primary Package Type (2019-2032)

Chapter 23. India Market

23.1. Overview
23.2. Economic Indicators
23.3. Demographics and Population Insights
23.4. Regional Hotspots
23.5. Growth Drivers
23.6. Challenges and Barriers
23.7. Competitive Strategies
23.8. Emerging Players
23.9. Import/Export Policies
23.10. Compliance Requirements
23.11. Emerging Investment Areas
23.12. Major Ongoing Projects
23.13. Market Size and Forecast
- 23.13.1. Market Revenue, by Type (2019-2032)
- 23.13.2. Market Revenue, by Primary Package Type (2019-2032)

Chapter 24. South Korea Market

24.1. Overview
24.2. Economic Indicators
24.3. Demographics and Population Insights
24.4. Regional Hotspots
24.5. Growth Drivers
24.6. Challenges and Barriers
24.7. Competitive Strategies
24.8. Emerging Players
24.9. Import/Export Policies
24.10. Compliance Requirements
24.11. Emerging Investment Areas
24.12. Major Ongoing Projects
24.13. Market Size and Forecast
- 24.13.1. Market Revenue, by Type (2019-2032)
- 24.13.2. Market Revenue, by Primary Package Type (2019-2032)

Chapter 25. Brazil Market

25.1. Overview
25.2. Economic Indicators
25.3. Demographics and Population Insights
25.4. Regional Hotspots
25.5. Growth Drivers
25.6. Challenges and Barriers
25.7. Competitive Strategies
25.8. Emerging Players
25.9. Import/Export Policies
25.10. Compliance Requirements
25.11. Emerging Investment Areas
25.12. Major Ongoing Projects
25.13. Market Size and Forecast
- 25.13.1. Market Revenue, by Type (2019-2032)
- 25.13.2. Market Revenue, by Primary Package Type (2019-2032)

Chapter 26. Mexico Market

26.1. Overview
26.2. Economic Indicators
26.3. Demographics and Population Insights
26.4. Regional Hotspots
26.5. Growth Drivers
26.6. Challenges and Barriers
26.7. Competitive Strategies
26.8. Emerging Players
26.9. Import/Export Policies
26.10. Compliance Requirements
26.11. Emerging Investment Areas
26.12. Major Ongoing Projects
26.13. Market Size and Forecast
- 26.13.1. Market Revenue, by Type (2019-2032)
- 26.13.2. Market Revenue, by Primary Package Type (2019-2032)

Chapter 27. U.A.E. Market

27.1. Overview
27.2. Economic Indicators
27.3. Demographics and Population Insights
27.4. Regional Hotspots
27.5. Growth Drivers
27.6. Challenges and Barriers
27.7. Competitive Strategies
27.8. Emerging Players
27.9. Import/Export Policies
27.10. Compliance Requirements
27.11. Emerging Investment Areas
27.12. Major Ongoing Projects
27.13. Market Size and Forecast
- 27.13.1. Market Revenue, by Type (2019-2032)
- 27.13.2. Market Revenue, by Primary Package Type (2019-2032)

Chapter 28. Saudi Arabia Market

28.1. Overview
28.2. Economic Indicators
28.3. Demographics and Population Insights
28.4. Regional Hotspots
28.5. Growth Drivers
28.6. Challenges and Barriers
28.7. Competitive Strategies
28.8. Emerging Players
28.9. Import/Export Policies
28.10. Compliance Requirements
28.11. Emerging Investment Areas
28.12. Major Ongoing Projects
28.13. Market Size and Forecast
- 28.13.1. Market Revenue, by Type (2019-2032)
- 28.13.2. Market Revenue, by Primary Package Type (2019-2032)

Chapter 29. South Africa Market

29.1. Overview
29.2. Economic Indicators
29.3. Demographics and Population Insights
29.4. Regional Hotspots
29.5. Growth Drivers
29.6. Challenges and Barriers
29.7. Competitive Strategies
29.8. Emerging Players
29.9. Import/Export Policies
29.10. Compliance Requirements
29.11. Emerging Investment Areas
29.12. Major Ongoing Projects
29.13. Market Size and Forecast
- 29.13.1. Market Revenue, by Type (2019-2032)
- 29.13.2. Market Revenue, by Primary Package Type (2019-2032)

Chapter 30. Company Profiles

Chapter 31. Appendix

31.1. Sources and References
31.2. Related Reports

Biologics CDMO Secondary Packaging Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)